ATE220901T1 - Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen - Google Patents

Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Info

Publication number
ATE220901T1
ATE220901T1 AT95919817T AT95919817T ATE220901T1 AT E220901 T1 ATE220901 T1 AT E220901T1 AT 95919817 T AT95919817 T AT 95919817T AT 95919817 T AT95919817 T AT 95919817T AT E220901 T1 ATE220901 T1 AT E220901T1
Authority
AT
Austria
Prior art keywords
lung
animal
hyperinflated
perfluorocarbs
mammals
Prior art date
Application number
AT95919817T
Other languages
English (en)
Inventor
Leland C Clark Jr
Original Assignee
Synthetic Blood International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Blood International filed Critical Synthetic Blood International
Application granted granted Critical
Publication of ATE220901T1 publication Critical patent/ATE220901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95919817T 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen ATE220901T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/242,310 US5674913A (en) 1994-05-13 1994-05-13 Method for assisting normal breathing in a mammal having a lung disorder
PCT/US1995/005993 WO1995031191A1 (en) 1994-05-13 1995-05-12 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders

Publications (1)

Publication Number Publication Date
ATE220901T1 true ATE220901T1 (de) 2002-08-15

Family

ID=22914268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919817T ATE220901T1 (de) 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Country Status (8)

Country Link
US (1) US5674913A (de)
EP (1) EP0758886B1 (de)
JP (1) JPH10505319A (de)
AT (1) ATE220901T1 (de)
AU (1) AU690277B2 (de)
CA (1) CA2190180C (de)
DE (1) DE69527524D1 (de)
WO (1) WO1995031191A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5840767A (en) * 1995-12-01 1998-11-24 Synthetic Blood International, Inc. Perfluorocarbons for biological gas exchange and method
US6167887B1 (en) * 1997-11-21 2001-01-02 Synthetic Blood International, Inc. Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
AU2000279747A1 (en) * 2000-07-20 2002-02-05 Otkrytoe Aktsionernoe Obschestvo Nauchno-Proizvodstvennaya Firma "Perftoran" Emulsion of perfluororganic compounds for medical purposes, method for producingsaid emulsion and methods for curing and preventing diseases with the aid of the emulsion
ES2305368T3 (es) * 2002-05-10 2008-11-01 THE PROCTER & GAMBLE COMPANY Tisu estampado en relieve que tiene fibras superficiales sueltas y metodo para su produccion.
US8535691B2 (en) * 2006-02-16 2013-09-17 Peach Technologies, LLC. Perflurochemical treatment process and apparatus
CN101443272A (zh) * 2006-05-15 2009-05-27 弗吉尼亚联邦大学 用于受控和持续产生并输送过氧化物的方法和组合物
EP2198869B1 (de) 2007-02-23 2015-09-16 Next 21 K.K. Trehalose für die behandlung oder vorbeugung von vasospasmus
EP2252333A4 (de) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc Wund- und gewebetherapeutika auf gasbasis
US8404752B2 (en) * 2008-07-18 2013-03-26 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
WO2011014247A1 (en) * 2009-07-28 2011-02-03 Oxygen Biotherapeutics, Inc. Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
WO2012044963A2 (en) 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4173654A (en) * 1977-01-03 1979-11-06 California Institute Of Technology Novel fluorohydrocarbons
WO1991003267A1 (en) * 1989-08-28 1991-03-21 Sekins K Michael Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
EP0583358B1 (de) * 1991-05-03 1998-12-02 Alliance Pharmaceutical Corporation Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5295953A (en) * 1992-05-26 1994-03-22 Hemagen/Pfc Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient

Also Published As

Publication number Publication date
CA2190180C (en) 2000-10-03
AU690277B2 (en) 1998-04-23
CA2190180A1 (en) 1995-11-23
JPH10505319A (ja) 1998-05-26
DE69527524D1 (de) 2002-08-29
EP0758886A1 (de) 1997-02-26
WO1995031191A1 (en) 1995-11-23
AU2549395A (en) 1995-12-05
US5674913A (en) 1997-10-07
EP0758886B1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE69527524D1 (de) Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen
Dörges et al. The laryngeal tube: a new simple airway device
Downes The historical evolution, current status, and prospective development of pediatric critical care
Auerbach et al. Inadequate oxygenation and ventilation using the esophageal gastric tube airway in the prehospital setting
Farrow et al. Fetal death due to nonlethal maternal carbon monoxide poisoning
ATE144142T1 (de) Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
Koch et al. Bronchoscopic findings in post-obstructive pulmonary oedema
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
Idris Reassessing the need for ventilation during CPR
Ratliff et al. Re-expansion Pulmonary Edema: A Rare But Life-Threatening Complication of a Commonly Performed Minor Surgical Procedure
WEST et al. Pulmonary function in cystic fibrosis of the pancreas
Anthonisen et al. Respiratory acidosis as a consequence of pulmonary edema
Lalonde et al. Increased early postburn fluid requirements and oxygen demands are predictive of the degree of airways injury by smoke inhalation
Eipe et al. Submental intubation for cancrum oris: a case report
Glasser et al. The use of spontaneous ventilation with constant-positive airway pressure in the treatment of salt water near drowning
Murray-Calderon et al. Laryngospasm and noncardiogenic pulmonary edema
Desai et al. Managing smoke inhalation injuries
Bailey et al. The role of continuous positive airway pressure during weaning from mechanical ventilation in cardiac surgical patients
Cherniack The effect of mechanical exsufflation on respiratory gas exchange in chronic pulmonary emphysema
Moore et al. Inhalational versus intravenous induction. A survey of emergency anaesthetic practice in the United Kingdom
Gilbertson Before intensive therapy?
REYNOLDS et al. Permissive hypercapnia and pressure-controlled ventilation as treatment of severe adult respiratory distress syndrome in a pediatric burn patient
Merten et al. Progressive pulmonary emphysema associated with congenital generalized elastolysis (cutis laxa)
Reynolds Respiratory Distress Syndrome: Methods of Mechanical Ventilation for Hyaline Membrane Disease
Bonica et al. Factors which affect ventilatory function during surgical pneumothorax

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties